These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 37523970)
1. Immune cells in pemphigus vulgaris and bullous Pemphigoid: From pathogenic roles to targeting therapies. Yuan Q; Yang W; Zhang X Int Immunopharmacol; 2023 Oct; 123():110694. PubMed ID: 37523970 [TBL] [Abstract][Full Text] [Related]
2. Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid. Hu Z; Zheng M; Guo Z; Zhou W; Zhou W; Yao N; Zhang G; Lu Q; Zhao M Clin Immunol; 2024 Jun; 263():110219. PubMed ID: 38631594 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune bullous dermatoses: a review. Patrício P; Ferreira C; Gomes MM; Filipe P Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152 [TBL] [Abstract][Full Text] [Related]
4. Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris. Ernst N; Friedrich M; Bieber K; Kasperkiewicz M; Gross N; Sadik CD; Zillikens D; Schmidt E; Ludwig RJ; Hartmann K J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):486-492. PubMed ID: 32596926 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related]
6. Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris. Ergun EZ; Aoki R; Horváth ON; Hartmann D; Satoh TK; Calabrese L; Aksu AEK; Gürel MS; Manav V; Flaig MJ; Sárdy M; Ruzicka T; French LE; Bağcı IS Exp Dermatol; 2023 Sep; 32(9):1412-1419. PubMed ID: 37260420 [TBL] [Abstract][Full Text] [Related]
7. Pemphigus and pemphigoid. Matsuoka LY Am Fam Physician; 1981 Aug; 24(2):113-5. PubMed ID: 7020393 [TBL] [Abstract][Full Text] [Related]
9. Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris. Schinner J; Cunha T; Mayer JU; Hörster S; Kind P; Didona D; Keber C; Hertl M; Worzfeld T; Juratli HA Front Immunol; 2023; 14():1203776. PubMed ID: 37415985 [TBL] [Abstract][Full Text] [Related]
10. The role of T cells in pemphigus vulgaris and bullous pemphigoid. Fang H; Li Q; Wang G Autoimmun Rev; 2020 Nov; 19(11):102661. PubMed ID: 32942041 [TBL] [Abstract][Full Text] [Related]
11. Current Clinical Trials in Pemphigus and Pemphigoid. Izumi K; Bieber K; Ludwig RJ Front Immunol; 2019; 10():978. PubMed ID: 31130959 [TBL] [Abstract][Full Text] [Related]
12. T cell control in autoimmune bullous skin disorders. Hertl M; Eming R; Veldman C J Clin Invest; 2006 May; 116(5):1159-66. PubMed ID: 16670756 [TBL] [Abstract][Full Text] [Related]
13. Blistering diseases in the mature patient. Lakoš Jukić I; Jerković Gulin S; Marinović B Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927 [TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases. Laskaris G; Sklavounou A; Stratigos J Oral Surg Oral Med Oral Pathol; 1982 Dec; 54(6):656-62. PubMed ID: 6760033 [TBL] [Abstract][Full Text] [Related]
15. Pemphigus Vulgaris and Bullous Pemphigoid of the Upper Aerodigestive Tract: A Review Article and Novel Approaches to Management. Hussain MH; Tanweer F; Sakagiannis G; Mair M; Mahmood S; Ashokkumar S ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):395-403. PubMed ID: 33902048 [TBL] [Abstract][Full Text] [Related]
16. [Autoimmune bullous skin diseases]. Joly P Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817 [TBL] [Abstract][Full Text] [Related]
17. New and emerging therapies in the treatment of blistering diseases. Korman NJ Dermatol Clin; 2000 Jan; 18(1):127-37, ix-x. PubMed ID: 10626118 [TBL] [Abstract][Full Text] [Related]